ADvantage Therapeutics Inc.
- Biotech or pharma, therapeutic R&D
ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a major focus on Alzheimer’s Disease (AD). We are in phase 2b in Europe, with a fast track ILAP designation in the UK..
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}